US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Yarrow Bioscience, Inc. - Common Stock
(NQ:
YARW
)
22.27
-1.33 (-5.64%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Yarrow Bioscience, Inc. - Common Stock
Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
September 14, 2026
From
Yarrow Bioscience, Inc.
Via
Business Wire
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering
September 10, 2026
From
Yarrow Bioscience, Inc.
Via
Business Wire
Yarrow Bioscience Announces Proposed Underwritten Public Offering
September 10, 2026
From
Yarrow Bioscience, Inc.
Via
Business Wire
Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
From
Yarrow Bioscience, Inc.
Via
Business Wire